| 伊赫亚,赵秸米,梁晓峰,Teo Yik Ying.新加坡新型冠状病毒疫苗免疫接种策略研究[J].中华流行病学杂志,2022,43(3):310-314 |
| 新加坡新型冠状病毒疫苗免疫接种策略研究 |
| Research on COVID-19 vaccination strategies in Singapore |
| 收稿日期:2021-11-25 出版日期:2022-03-21 |
| DOI：10.3760/cma.j.cn112338-20211125-00919 |
| 中文关键词: 新型冠状病毒 免疫接种 防控措施 新加坡 |
| 英文关键词: 2019-nCoV Vaccination Prevention and control Singapore |
| 基金项目:2021年中国科协“一带一路”国际科技组织合作平台建设项目（2021ZZGJB0522） |
|
| 摘要点击次数: 5291 |
| 全文下载次数: 1158 |
| 中文摘要: |
| 截至2021年12月31日，新加坡累计报告已有4 758 601人完成至少一剂次新型冠状（新冠）病毒疫苗接种，4 714 655人完成两剂次新冠病毒疫苗接种，2 207 341人完成新冠病毒疫苗加强针接种。本研究通过深入分析新加坡新冠病毒疫苗接种现状，解读新加坡国家疫苗接种计划内容，系统梳理新加坡新冠病毒疫苗上门接种、疫苗接种差异化管理、拒绝接种疫苗者感染新冠病毒后自付医药费等具体措施，为我国新冠病毒疫苗接种工作提供参考。 |
| 英文摘要: |
| As of December 31, 2021, Singapore reported that 4 758 601 had completed at least one dose of COVID-19 vaccination, 4 714 655 had completed two doses of COVID-19 vaccination, and 2 207 341 had received one booster shot of COVID-19 vaccine. This article analyses the current performance of COVID-19 vaccination in Singapore, interprets the content of Singapore's National Vaccination Programme, and systematically introduces specific measures of COVID-19 vaccination in Singapore, such as door-to-door vaccination, vaccination differentiated management, and self-payment of medical expenses for those who refuse to be vaccinated, to provide reference for the COVID-19 vaccination in China. |
|
查看全文
Html全文
查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
